Neil Desai - Mar 18, 2022 Form 4 Insider Report for Aadi Bioscience, Inc. (AADI)

Role
Officer, Director, 10%+ Owner
Signature
/s/ Scott Giacobello, as Attorney-in-Fact
Stock symbol
AADI
Transactions as of
Mar 18, 2022
Transactions value $
-$71,234
Form type
4
Date filed
3/22/2022, 05:34 PM
Previous filing
Sep 10, 2021
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AADI Common Stock Sale -$71.2K -3.55K -0.18% $20.07 1.92M Mar 18, 2022 See footnote F1, F2, F3
holding AADI Common Stock 640K Mar 18, 2022 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 20, 2021 by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 3,550 shares sold in the price range of $20.00 to $20.09 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.
F4 Shares held by Anishka Irrevocable 2016 Trust dated October 19, 2016 (the "Irrevocable Trust"). The Reporting Person disclaims beneficial ownership of the shares held by the Irrevocable Trust except to the extent of any pecuniary interest therein, and this filing shall not be deemed an admission that Dr. Desai is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.